Invention Grant
- Patent Title: Inhalable formulation
-
Application No.: US15519460Application Date: 2015-10-16
-
Publication No.: US10653704B2Publication Date: 2020-05-19
- Inventor: Mukul Dalvi , Jacquelyn McCabe
- Applicant: Teva Branded Pharmaceutical Products R&D, Inc.
- Applicant Address: US PA Frazer
- Assignee: Teva Branded Pharmaceutical Products R&D, Inc.
- Current Assignee: Teva Branded Pharmaceutical Products R&D, Inc.
- Current Assignee Address: US PA Frazer
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2015/055916 WO 20151016
- International Announcement: WO2016/061445 WO 20160421
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K9/12 ; A61K9/00
Abstract:
This invention provides a process for preparing an inhalable active pharmaceutical ingredient comprising the steps of heating a suspension of an active pharmaceutical ingredient in a liquefied propellant in a vessel, evaporating the propellant and collecting the resultant powder.
Public/Granted literature
- US20170239269A1 Inhalable Formulation Public/Granted day:2017-08-24
Information query
